OSUR (OraSure Technologies, Inc.) Stock Financials & Earnings | Market Cap Arena

OSUR (OraSure Technologies, Inc.) Stock Financials & Earnings | Market Cap Arena

OSUROraSure Technologies, Inc.

Mkt Cap$230M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Revenue (TTM)$115M

Net Income (TTM)-$69M

EPS (TTM)-$0.93

Free Cash Flow (TTM)-$53M

Gross Margin38.2%

Op. Margin-59.2%

Net Margin-59.8%

FCF Margin-46.3%

P/S Ratio (TTM)2.0x

P/E Ratio (TTM)—

YoY Rev Growth-38.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$155M	$66M	$25M
Q2 23	$85M	$26M	-$6M
Q3 23	$89M	$44M	$17M
Q4 23	$76M	$36M	$8M
Q1 24	$54M	$24M	-$3M
Q2 24	$54M	$26M	-$34K
Q3 24	$40M	$17M	-$6M
Q4 24	$37M	$14M	-$12M
Q1 25	$30M	$11M	-$18M
Q2 25	$31M	$12M	-$17M
Q3 25	$27M	$10M	-$16M
Q4 25	$27M	$11M	-$17M

Valuation

Quarter	P/S	P/E
Q1 23	0.5x	7.7x
Q2 23	0.5x	5.2x
Q3 23	0.5x	4.7x
Q4 23	0.6x	4.3x
Q1 24	0.8x	10.1x
Q2 24	0.8x	8.5x
Q3 24	1.0x	20.2x
Q4 24	1.2x	—
Q1 25	1.4x	—
Q2 25	1.7x	—
Q3 25	1.8x	—
Q4 25	2.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$6M	$2M
Q2 23	$57M	$54M
Q3 23	$37M	$35M
Q4 23	$41M	$40M
Q1 24	$7M	$5M
Q2 24	$8M	$6M
Q3 24	$13M	$13M
Q4 24	$109K	-$347K
Q1 25	-$20M	-$20M
Q2 25	-$10M	-$12M
Q3 25	-$10M	-$11M
Q4 25	-$9M	-$10M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$4M
Q2 23	$3M
Q3 23	$2M
Q4 23	$1M
Q1 24	$2M
Q2 24	$2M
Q3 24	$145K
Q4 24	$456K
Q1 25	$420K
Q2 25	$2M
Q3 25	$919K
Q4 25	$922K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+128.9%	+54.4%
Q2 23	+6.5%	+0.6%
Q3 23	-23.4%	-33.8%
Q4 23	-38.3%	-37.3%
Q1 24	-65.1%	-55.6%
Q2 24	-36.4%	-40.7%
Q3 24	-55.2%	-36.9%
Q4 24	-50.7%	-28.1%
Q1 25	-44.7%	-16.2%
Q2 25	-42.5%	-10.7%
Q3 25	-32.1%	-6.1%
Q4 25	-28.5%	-11.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	1.7%
Q2 23	$2M	2.8%
Q3 23	$3M	2.9%
Q4 23	$3M	4.1%
Q1 24	$3M	5.5%
Q2 24	$3M	6.1%
Q3 24	$3M	7.2%
Q4 24	$3M	7.3%
Q1 25	$3M	9.0%
Q2 25	$3M	10.1%
Q3 25	$3M	10.5%
Q4 25	$3M	10.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$11M	$30M
Q2 23	$8M	$25M
Q3 23	$9M	$19M
Q4 23	$7M	$21M
Q1 24	$8M	$20M
Q2 24	$6M	$19M
Q3 24	$6M	$17M
Q4 24	$6M	$19M
Q1 25	$9M	$20M
Q2 25	$11M	$18M
Q3 25	$10M	$16M
Q4 25	$11M	$16M

Revenue Segments

Quarter	Other Revenues	Product And Services
Q1 23	$2M	$153M
Q2 23	$703K	$85M
Q3 23	$173K	$89M
Q1 24	$353K	$54M
Q2 24	$386K	$54M
Q3 24	$264K	$40M
Q1 25	$934K	$29M
Q2 25	$1M	$30M
Q3 25	$2M	$25M
Q4 25	$2M	$25M

Revenue by Geography

Quarter	Europe	Other Foreign Countries	United States	Africa
Q1 23	$2M	$8M	$145M	—
Q2 23	$2M	$9M	$74M	—
Q3 23	$2M	$9M	$78M	—
Q1 24	$2M	$7M	$45M	—
Q2 24	$2M	$8M	$44M	—
Q3 24	$2M	$12M	$25M	—
Q1 25	$2M	$770K	$20M	$7M
Q2 25	$2M	$1M	$20M	$8M
Q3 25	$1M	$1M	$20M	$5M
Q4 25	$2M	$2M	$18M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$90M	$22M	$112M
Q2 23	$186M	$0	$186M
Q3 23	$218M	$7M	$225M
Q4 23	$290M	$0	$290M
Q1 24	$247M	$17M	$264M
Q2 24	$258M	$9M	$267M
Q3 24	$279M	$0	$279M
Q4 24	$268M	$0	$268M
Q1 25	$248M	$0	$248M
Q2 25	$235M	$0	$235M
Q3 25	$216M	$0	$216M
Q4 25	$199K	$0	$199K

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	74M	+1.0%
Q2 23	73M	-0.9%
Q3 23	74M	+1.4%
Q4 23	75M	+0.9%
Q1 24	74M	-1.4%
Q2 24	74M	+0.3%
Q3 24	75M	+0.6%
Q4 24	74M	-0.2%
Q1 25	75M	+0.6%
Q2 25	75M	-0.4%
Q3 25	73M	-2.1%
Q4 25	72M	-2.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$333K	320
FY 15	$367K	326
FY 16	$378K	325
FY 17	$443K	377
FY 18	$457K	398
FY 19	$328K	472
FY 20	$301K	570
FY 21	$298K	785
FY 22	$461K	840
FY 23	$636K	638
FY 24	$291K	638
FY 25	$180K	638